The equity of Diagnostic Related Group "All Payor" hospital payment and gynecology diagnostic related groups

Eric Munoz, Vicki Seltzer, Jonathan Goldstein, Teresa Benacquista, Katherine Mulloy, Leslie Wise

Research output: Contribution to journalArticle

Abstract

Previous work by our group had suggested that some Diagnostic Related Groups did not adequately compensate for patients with multiple complications and comorbidities. However, this question had never been studied for gynecology Diagnostic Related Groups. We analyzed resource consumption in the 15 gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities using the new Diagnostic Related Group prospective "All Payor System" in effect at our hospital. Analysis of 2920 gynecology patients for a 3-year period by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in the gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities demonstrated that patients with more complications and comorbidities per Diagnostic Related Group for each payor generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under Diagnostic Related Group payment, more outliers, and a higher mortality compared with patients in these same Diagnostic Related Groups with fewer complications and comorbidities. These findings suggest that new prospective Diagnostic Related Group All Payor Systems may be inequitable for certain groups of gynecology patients. Gynecology Diagnostic Related Groups should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under Diagnostic Related Group All Payor Systems.

Original languageEnglish (US)
Pages (from-to)831-837
Number of pages7
JournalObstetrics and Gynecology
Volume74
Issue number6
StatePublished - Dec 1989
Externally publishedYes

Fingerprint

Diagnosis-Related Groups
Gynecology
Comorbidity
Length of Stay
Blue Cross Blue Shield Insurance Plans
Hospital Costs
Medicaid
Medicare
Insurance

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The equity of Diagnostic Related Group "All Payor" hospital payment and gynecology diagnostic related groups. / Munoz, Eric; Seltzer, Vicki; Goldstein, Jonathan; Benacquista, Teresa; Mulloy, Katherine; Wise, Leslie.

In: Obstetrics and Gynecology, Vol. 74, No. 6, 12.1989, p. 831-837.

Research output: Contribution to journalArticle

Munoz, Eric ; Seltzer, Vicki ; Goldstein, Jonathan ; Benacquista, Teresa ; Mulloy, Katherine ; Wise, Leslie. / The equity of Diagnostic Related Group "All Payor" hospital payment and gynecology diagnostic related groups. In: Obstetrics and Gynecology. 1989 ; Vol. 74, No. 6. pp. 831-837.
@article{e0596926d3b94c96aa1dd1e98b452705,
title = "The equity of Diagnostic Related Group {"}All Payor{"} hospital payment and gynecology diagnostic related groups",
abstract = "Previous work by our group had suggested that some Diagnostic Related Groups did not adequately compensate for patients with multiple complications and comorbidities. However, this question had never been studied for gynecology Diagnostic Related Groups. We analyzed resource consumption in the 15 gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities using the new Diagnostic Related Group prospective {"}All Payor System{"} in effect at our hospital. Analysis of 2920 gynecology patients for a 3-year period by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in the gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities demonstrated that patients with more complications and comorbidities per Diagnostic Related Group for each payor generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under Diagnostic Related Group payment, more outliers, and a higher mortality compared with patients in these same Diagnostic Related Groups with fewer complications and comorbidities. These findings suggest that new prospective Diagnostic Related Group All Payor Systems may be inequitable for certain groups of gynecology patients. Gynecology Diagnostic Related Groups should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under Diagnostic Related Group All Payor Systems.",
author = "Eric Munoz and Vicki Seltzer and Jonathan Goldstein and Teresa Benacquista and Katherine Mulloy and Leslie Wise",
year = "1989",
month = "12",
language = "English (US)",
volume = "74",
pages = "831--837",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The equity of Diagnostic Related Group "All Payor" hospital payment and gynecology diagnostic related groups

AU - Munoz, Eric

AU - Seltzer, Vicki

AU - Goldstein, Jonathan

AU - Benacquista, Teresa

AU - Mulloy, Katherine

AU - Wise, Leslie

PY - 1989/12

Y1 - 1989/12

N2 - Previous work by our group had suggested that some Diagnostic Related Groups did not adequately compensate for patients with multiple complications and comorbidities. However, this question had never been studied for gynecology Diagnostic Related Groups. We analyzed resource consumption in the 15 gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities using the new Diagnostic Related Group prospective "All Payor System" in effect at our hospital. Analysis of 2920 gynecology patients for a 3-year period by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in the gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities demonstrated that patients with more complications and comorbidities per Diagnostic Related Group for each payor generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under Diagnostic Related Group payment, more outliers, and a higher mortality compared with patients in these same Diagnostic Related Groups with fewer complications and comorbidities. These findings suggest that new prospective Diagnostic Related Group All Payor Systems may be inequitable for certain groups of gynecology patients. Gynecology Diagnostic Related Groups should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under Diagnostic Related Group All Payor Systems.

AB - Previous work by our group had suggested that some Diagnostic Related Groups did not adequately compensate for patients with multiple complications and comorbidities. However, this question had never been studied for gynecology Diagnostic Related Groups. We analyzed resource consumption in the 15 gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities using the new Diagnostic Related Group prospective "All Payor System" in effect at our hospital. Analysis of 2920 gynecology patients for a 3-year period by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in the gynecology Diagnostic Related Groups that were not stratified for complications or comorbidities demonstrated that patients with more complications and comorbidities per Diagnostic Related Group for each payor generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under Diagnostic Related Group payment, more outliers, and a higher mortality compared with patients in these same Diagnostic Related Groups with fewer complications and comorbidities. These findings suggest that new prospective Diagnostic Related Group All Payor Systems may be inequitable for certain groups of gynecology patients. Gynecology Diagnostic Related Groups should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under Diagnostic Related Group All Payor Systems.

UR - http://www.scopus.com/inward/record.url?scp=0024329622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024329622&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 831

EP - 837

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -